Signaling Pathways - constitutive androstane receptor (CAR) - Vitamin D receptors (VDRs) - Adenosine A2A Receptors - Adenosine A2B Receptors
清除全部
- B5904 Regadenoson1 Citation中文名: 类伽腺苷Target: Adenosine A2A ReceptorsSummary: A2A腺苷受体激动剂
- B5612 BAY 60-6583Target: Adenosine A2B ReceptorsSummary: A2B受体的强效激动剂
- B7468 CITCO1 CitationTarget: constitutive androstane receptor (CAR)Summary: 组成型雄激素受体(CAR)激动剂
- B6995 SCH 58261Target: Adenosine A2A ReceptorsSummary: A2A腺苷受体竞争性拮抗剂
- B2140 Calcifediol中文名: 骨化二醇Target: Vitamin D receptors (VDRs)Summary: 维生素D3的主要循环形式
- B2091 Doxercalciferol1 Citation中文名: 度骨化醇Target: Vitamin D receptors (VDRs)Summary: 维生素D受体激活剂
- A8463 Lithocholic Acid中文名: 石胆酸Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)Summary: 维生素D受体PXR和FXR的激活剂
- A8454 Istradefylline (KW-6002)中文名: 伊曲茶碱Target: Adenosine A2A ReceptorsSummary: 选择性A2A受体拮抗剂
- A3885 TozadenantTarget: Adenosine A2A ReceptorsSummary: 腺苷2A受体拮抗剂
- A3735 PreladenantTarget: Adenosine A2A ReceptorsSummary: 腺苷A2A受体拮抗剂